Canada_IPAP - Anglo-Canadian Collaboration on Antimicrobial resistance

抗菌素耐药性(AMR)是一个主要的公共卫生问题，因为耐药细菌的繁殖日益降低了我们最广泛使用的抗生素在治疗细菌疾病方面的有效性。目前的生物科学革命正在创造新的工具，这些工具提供了解决环境中的AMR问题的机会，并为新的应用领域创造了“面向未来”的技术，针对AMR问题。成功利用有赖于加强对基础科学的理解，以及能够在实地应用和部署以进行实时监测，以便更好地了解AMR在环境中的出现和传播。因此，英国-加拿大抗菌素耐药性合作(ACCAMAR)旨在加强那些处于微生物基因组学、代谢能力和社区互动前沿的人与那些设计下一代环境保护技术和人类风险暴露和缓解的人之间的联系。

Antimicrobial resistance (AMR) is a major public health concern as the proliferation of antibiotic-resistant bacteria increasingly reduces the effectiveness of our most widely used antibiotics in the treatment of bacterial diseases. The current revolution in biosciences is creating new tools that offer the chance to tackle AMR issues in the environment and create 'future-proof' technologies for new areas of application, targeting AMR issues. Successful exploitation depends on combining an enhanced understanding of the fundamental science with an ability to apply and deploy in the field for real-time monitoring to better understand the emergence and dissemination of AMR in the environment. The Anglo-Canadian Collaboration on Antimicrobial resistance (ACCAMAR) thus aims to strengthen the links between those working at the forefront of microbial genomics, metabolic capabilities, and community interactions; and those designing next-generation environmental protection technologies and human risk exposure and mitigations.